Evidence map›Paper›PMID 33772096›Full record

ArticleCommunications biology2021

Inhibiting LXRα phosphorylation in hematopoietic cells reduces inflammation and attenuates atherosclerosis and obesity in mice.

Maud Voisin, Elina Shrestha, Claire Rollet, Cyrus A Nikain, Tatjana Josefs, Mélanie Mahé, Tessa J Barrett, Hye Rim Chang, Rachel Ruoff, Jeffrey A Schneider and 11 more

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 3 institutions in 2 countries.

Maud VoisinDepartment of Microbiology, NYU School of Medicine, New York, NY, USA.
Elina ShresthaDepartment of Microbiology, NYU School of Medicine, New York, NY, USA.
Claire RolletDepartment of Microbiology, NYU School of Medicine, New York, NY, USA.
Cyrus A NikainDivision of Cardiology, Marc and Ruti Bell Program in Vascular Biology, Department of Medicine, NYU School of Medicine, New York, NY, USA.
Tatjana JosefsDivision of Cardiology, Marc and Ruti Bell Program in Vascular Biology, Department of Medicine, NYU School of Medicine, New York, NY, USA.
Mélanie MahéDepartment of Microbiology, NYU School of Medicine, New York, NY, USA.
Tessa J BarrettDivision of Cardiology, Marc and Ruti Bell Program in Vascular Biology, Department of Medicine, NYU School of Medicine, New York, NY, USA.
Hye Rim ChangDivision of Endocrinology, Department of Medicine, NYU School of Medicine, New York, NY, USA.
Rachel RuoffDepartment of Microbiology, NYU School of Medicine, New York, NY, USA.
Jeffrey A SchneiderDepartment of Microbiology, NYU School of Medicine, New York, NY, USA.
Michela L GarabedianDivision of Cardiology, Marc and Ruti Bell Program in Vascular Biology, Department of Medicine, NYU School of Medicine, New York, NY, USA.
Chris ZoumadakisOrdaos, Inc, New York, NY, USA.
Chi YunOrdaos, Inc, New York, NY, USA.
Bara BadwanOrdaos, Inc, New York, NY, USA.
Emily J BrownDivision of Cardiology, Marc and Ruti Bell Program in Vascular Biology, Department of Medicine, NYU School of Medicine, New York, NY, USA.
Adam C MarDepartment of Neuroscience and Physiology, NYU School of Medicine, New York, NY, USA.ORCID 0000-0002-2095-2936
Robert J SchneiderDepartment of Microbiology, NYU School of Medicine, New York, NY, USA.
Ira J GoldbergDivision of Endocrinology, Department of Medicine, NYU School of Medicine, New York, NY, USA.
Inés Pineda-TorraCentre for Cardiometabolic and Vascular Science, University College of London, London, UK.ORCID 0000-0002-7349-2208
Edward A FisherDivision of Cardiology, Marc and Ruti Bell Program in Vascular Biology, Department of Medicine, NYU School of Medicine, New York, NY, USA. edward.fisher@nyulangone.org.ORCID 0000-0001-9802-143X
Michael J GarabedianDepartment of Microbiology, NYU School of Medicine, New York, NY, USA. michael.garabedian@nyulangone.org.ORCID 0000-0001-8915-7378
New York University · USColumbia University Irving Medical Center · USUniversity College London · GB

Funding

Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ADRIANA HEGUY · 1985 to 2026
$83.1M
Triglycerides, Diabetes and Cardiovascular DiseaseP01HL151328 · NHLBI · UNIVERSITY OF WASHINGTON · PI Karin E Bornfeldt · 2020 to 2026
$19.6M
Regulation of LXR alpha by glucose & cholesterol in diabetes & atherosclerosisR01HL117226 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI FISHER, EDWARD A, GARABEDIAN, MICHAEL J. · 2014 to 2017
$2.1M
Medical Research Council G0801278NCI NIH HHS P30 CA016087NHLBI NIH HHS P01 HL151328NHLBI NIH HHS R01 HL117226
6 · The paper itself

Abstract

Atherosclerosis and obesity share pathological features including inflammation mediated by innate and adaptive immune cells. LXRα plays a central role in the transcription of inflammatory and metabolic genes. LXRα is modulated by phosphorylation at serine 196 (LXRα pS196), however, the consequences of LXRα pS196 in hematopoietic cell precursors in atherosclerosis and obesity have not been investigated. To assess the importance of LXRα phosphorylation, bone marrow from LXRα WT and S196A mice was transplanted into Ldlr

Indexed as

AnimalsAtherosclerosisHematopoietic Stem CellsHematopoietic Stem Cell TransplantationInflammationLiver X ReceptorsMaleMiceObesityPhosphorylationLiver X Receptors

Identifiers

PMID33772096
PMCPMC7997930
OpenAlexW3139176522

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.